Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.01B |
| 2 |
Dell
DELL
|
+$705M |
| 3 |
T-Mobile US
TMUS
|
+$643M |
| 4 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$621M |
| 5 |
Palantir
PLTR
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.41B |
| 2 |
Walmart Inc
WMT
|
+$1.29B |
| 3 |
NVIDIA
NVDA
|
+$1.29B |
| 4 |
Apple
AAPL
|
+$1.11B |
| 5 |
Tesla
TSLA
|
+$974M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.65% |
| 2 | Financials | 0.97% |
| 3 | Industrials | 0.85% |
| 4 | Consumer Discretionary | 0.81% |
| 5 | Healthcare | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11176
IT Tech Packaging
ITP
$2.82M
| $9.11K | ﹤0.01% |
+50,041
| New | +$10.3K |
|
|
WGRX
11177
DELISTED
Wellgistics Health
WGRX
| $9.06K | ﹤0.01% |
1,880
+1,044
| +125% | +$14.3K |
|
|
QTEX
11178
QTREX Quantum
QTEX
$46.2M
| $8.95K | ﹤0.01% |
+20,047
| New | +$13.6K |
|
11179
iSpecimen
ISPC
$2.63M
| $8.73K | ﹤0.01% |
1,391
+1,039
| +295% | +$11.7K |
|
|
JBDI
11180
JBDI Holdings
JBDI
$10.9M
| $8.66K | ﹤0.01% |
+7,420
| New | +$10.8K |
|
11181
Calidi Biotherapeutics
CLDI
$1.8M
| $8.31K | ﹤0.01% |
34,802
+23,311
| +203% | +$17.5K |
|
11182
Eterna Therapeutics
ERNA
$4.05M
| $8.19K | ﹤0.01% |
+1,647
| New | +$26.3K |
|
|
MAPS
11183
DELISTED
WM TECHNOLOGY INC A
MAPS
| $8.19K | ﹤0.01% |
+12,442
| New | +$9.13K |
|
11184
Galmed Pharmaceuticals
GLMD
$4.95M
| $8.06K | ﹤0.01% |
16,445
+4,310
| +36% | +$2.91K |
|
11185
Recon Technology
RCON
$32.6M
| $8.05K | ﹤0.01% |
+10,726
| New | +$13.7K |
|
11186
PUT
Humacyte
HUMA
$181M
| $7.89K | ﹤0.01% |
13,000
-300
| -2% | -$312 |
|
|
SCNX
11187
Scienture Holdings
SCNX
$15.5M
| $7.88K | ﹤0.01% |
+27,636
| New | +$12.6K |
|
|
DLXY
11188
Delixy Holdings
DLXY
$6.84M
| $7.79K | ﹤0.01% |
+14,979
| New | +$12.9K |
|
11189
PharmaCyte Biotech
PMCB
$6.44M
| $7.67K | ﹤0.01% |
11,530
+139
| +1% | +$106 |
|
|
CNCKW
11190
Coincheck Group Warrant expiring 12/10/2029
CNCKW
$1.46M
| $7.64K | ﹤0.01% |
44,937
| – | – |
|
|
QUCY
11191
Quantum Cyber N.V.
QUCY
$25.3M
| $7.63K | ﹤0.01% |
16,093
-2,344
| -13% | -$2.06K |
|
11192
CALL
Myomo
MYO
$38.6M
| $7.43K | ﹤0.01% |
+11,000
| New | +$9.02K |
|
11193
Ensysce Biosciences
ENSC
$3.95M
| $7.31K | ﹤0.01% |
+13,570
| New | +$8.61K |
|
|
OFAL
11194
OFA Group
OFAL
$2.77M
| $7.3K | ﹤0.01% |
+14,382
| New | +$6.59K |
|
|
IPST
11195
IP Strategy Holdings
IPST
$1.57M
| $7.19K | ﹤0.01% |
+1,362
| New | +$25.1K |
|
|
CAPT
11196
DELISTED
Captivision
CAPT
| $6.94K | ﹤0.01% |
17,613
-7,523
| -30% | -$3.56K |
|
|
PASW
11197
Ping An Biomedical
PASW
$14.7M
| $6.93K | ﹤0.01% |
+52,518
| New | +$11K |
|
11198
Hitek Global
HKIT
$28.7M
| $6.81K | ﹤0.01% |
+32
| New | +$187K |
|
|
WETO
11199
Wetour Robotics
WETO
$2.46M
| $6.69K | ﹤0.01% |
+16,314
| New | +$9.47K |
|
11200
HeartCore Enterprises
HTCR
$3.1M
| $6.67K | ﹤0.01% |
1,487
-4,172
| -74% | -$22.4K |
|
Similar funds
Jane Street's Q1 2026 Portfolio in Review
As of Q1 2026, Jane Street held 13,677 positions worth $777B, up 17% from $662B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street deployed $153B of net new capital in Q1 2026, opening 2,619 new positions and adding to 4,818 existing holdings. Its largest new stake was iShares Core US Aggregate Bond ETF: 2,411,981 shares worth $239M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 2.8% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.41B trimmed.
- Jane Street's largest Q1 2026 buy was iShares Core US Aggregate Bond ETF: 2,411,981 shares worth $239M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $7.01B increase.
- Jane Street's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $1.41B.
- Jane Street fully exited VanEck Gold Miners ETF in Q1 2026, selling an estimated $265M.
- Jane Street's ten largest holdings make up 34% of its $777B portfolio in Q1 2026.
- Jane Street opened 2,619 new positions and closed 2,274 in Q1 2026.
- Jane Street's portfolio value rose 17% quarter-over-quarter to $777B.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.